Back to Search
Start Over
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
- Source :
- Journal of Clinical Oncology; 7/1/2024, Vol. 42 Issue 19, p2317-2326, 15p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 19
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178087381
- Full Text :
- https://doi.org/10.1200/JCO.23.02110